Navigation Links
Snake venom studies yield insights for development of therapies for heart disease and cancer
Date:7/29/2010

BETHESDA, Md., July 29, 2010 Researchers seeking to learn more about stroke by studying how the body responds to toxins in snake venom are this week releasing new findings that they hope will aid in the development of therapies for heart disease and, surprisingly, cancer.

The Japanese team is reporting in a Journal of Biological Chemistry "Paper of the Week" that they are optimistic that inhibiting a protein found on the surface of blood cells known as platelets may combat both irregular blood clotting and the spread of certain cancers throughout the body.

"The finding that platelets not only play a role in blood clotting but also in the development of vessels that allow tumors to flourish was quite unexpected and paves the way for new research on the role or roles of platelets," says Katsue Suzuki-Inoue, the associate professor at the University of Yamanashi who oversaw the 13-person team's work in professor Yukio Ozaki's laboratory.

About platelets, blood clots and stroke

Under normal conditions, platelets are activated to become sticky when blood vessels are injured, and their clumping together (aggregation or clotting) naturally stops bleeding. But, irregular platelet aggregation caused by disease can lead to dangerous clots or even stroke if a clot clogs or bursts in a vessel that carries oxygen and nutrients to the brain.

"When a blood clot, or thrombus, forms during the body's normal repair process, it's doing its job," says Suzuki-Inoue. "But, thrombotic diseases, such as heart attack and stroke, are leading causes of death in developed countries. Understanding and manipulating the underlying chemical reactions could help us save many lives."

But what does this have to do with snake venom? It's sort of a long story.

How venom can prevent or cause clotting

"Snake venom contains a vast number of toxins that target proteins in platelets," says Yonchol Shin, a
'/>"/>

Contact: Angela Hopp
ahopp@asbmb.org
301-634-7389
American Society for Biochemistry and Molecular Biology
Source:Eurekalert

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Good Bye, Snake Oil! Grab your Orange Juice and Daily Virus Viper™ to Safeguard Against Micro-nutrient Deficiencies
2. CIHR team grant to fund multidisciplinary breast cancer survivorship studies
3. FDA accepts historical controls for epilepsy monotherapy studies
4. Studies explore effects of war on former child soldiers
5. Pediatric clinical studies appear prone to bias, Hopkins review shows
6. Studies of womens attitudes to social egg freezing find reasons differ with age
7. Studies confirm presence, severity of pollution in national parks
8. Vitamin D Deficiency Linked to Diabetes, Metabolic Syndrome in Studies
9. 2 studies: Social factors, super users and urban emergency departments
10. MSU team studies connection between statins, tendon ruptures
11. Quincy Bioscience Launches HOPETrials.com; Research Studies More Accessible For Participants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2012)... Reporter , , TUESDAY, May 22 (HealthDay News) -- ... procedure, which involves threading a camera through the ... But a new study has found that patients ... less time-consuming CT-based colon scan. Colonoscopy ... colon cancer screening. Computed tomography (CT) colonography -- ...
(Date:5/23/2012)... in the United Kingdom have determined that azithromycin, ... can be an effective treatment option for patients ... complication that occurs in the majority of patients ... leading cause of mortality after the first year ... body repeatedly rejects the transplanted lung tissue. The ...
(Date:5/22/2012)... Children born with cleft lip, cleft palate and ... appearance. , Patients can face serious airway, feeding, ... and psychological challenges, Laura Swibel Rosenthal, MD, of ... the June 2012 issue of Otolaryngologic Clinics ... patients with craniofacial syndromes is complex," Rosenthal and ...
(Date:5/22/2012)... -- Researchers at Barrow Neurological Institute at St. ... and why the public perceives some magic tricks ... in military tactics, marketing and sports. , Susana ... and Stephen Macknik, PhD, of Barrow,s Laboratory of ... into magic and illusions. Their most recent original ...
(Date:5/22/2012)... (May 22, 2012) Scientists at Virginia Commonwealth ... closer to developing a new therapy for acute ... agents obatoclax and sorafenib kill leukemia cells much ... are administered individually., Recently published in the journal ... Steven Grant, M.D., Shirley Carter Olsson and Sture ...
Breaking Medicine News(10 mins):Health News:Patients Prefer More Invasive Form of Colon Scan: Study 2Health News:Patients Prefer More Invasive Form of Colon Scan: Study 3Health News:Study shows antibiotic improves respiratory function in lung transplant patients 2Health News:Cleft lip/palate cause much more than cosmetic problems 2Health News:Barrow researchers use magic for discoveries 2Health News:VCU Massey Cancer Center sees potential in novel leukemia treatment 2Health News:VCU Massey Cancer Center sees potential in novel leukemia treatment 3
... 1 Community-based oral health,programs in Michigan, Ohio, ... to $5,000 from the Delta Dental Foundation,s third ... by Nancy E. Hostetler,senior vice president of the ... of $70,000 will be awarded in competitive grants,this ...
... Ophthalmology, the journal of the American Academy of ... degeneration and on nearsightedness in school children, as well ... cancer. , Age-Related Macular Degeneration (AMD) in an ... the central vision needed for reading, driving, and other ...
... the University of Pennsylvania School of Medicine have discovered that ... level of bile in the liver. FOXA2 may become the ... regulation of bile salts. The study was published online this ... in the liver, is stored in the gall bladder and ...
... completion of health risk assessment resulted in a 65% employee completion rate; ... ... 1, 2008 -- Employers are increasingly using incentives as the carrot to ... brief from HealthFitness (OTC BB: HFIT) zeros in on the use of ...
... comfortable, wear-anywhere posture support/brace, designed to combat rounded shoulders syndrome, which ... of time working at a computer, more people are suffering the ... comfort and can be worn everyday. , ... (PRWEB) ...
... for children impacted by ... HIV and AIDS, - Mexico City event a chance to ... ... warned that the world,s biggest conference on HIV and AIDS will miss,the mark unless attendees ...
Other Medicine News:Health News:Delta Dental Foundation Calls for Applicants for Annual Community Mini-Grant Program 2Health News:Highlights from the August 2008 issue of Ophthalmology 2Health News:Highlights from the August 2008 issue of Ophthalmology 3Health News:Highlights from the August 2008 issue of Ophthalmology 4Health News:Penn researchers find a new role for a 'Foxy Old Gene' 2Health News:HealthFitness Guides Incentives Strategy to Spark Participation in American Electric Power's Employee Health and Wellness Initiative New Issue Brief Highlights AEP program, Outlines Elements for Success 2Health News:HealthFitness Guides Incentives Strategy to Spark Participation in American Electric Power's Employee Health and Wellness Initiative New Issue Brief Highlights AEP program, Outlines Elements for Success 3Health News:Bad Backs Essential Shoulder Brace - Now Available at badbackstore.com 2Health News:Bad Backs Essential Shoulder Brace - Now Available at badbackstore.com 3Health News:Bad Backs Essential Shoulder Brace - Now Available at badbackstore.com 4Health News:International AIDS Conference an 'Expensive Talking Shop' Unless More Done for Children 2Health News:International AIDS Conference an 'Expensive Talking Shop' Unless More Done for Children 3
(Date:5/22/2012)... 2012  MusclePharm Corporation (OTCBB: MSLP.OB), a nutritional ... that it has signed Major League Baseball phenom ... agreement were not disclosed. Harper, a ... his professional baseball debut on April 28.  He ... the 2010 baseball draft, after earning the 2010 ...
(Date:5/22/2012)... 2012  Boehringer Ingelheim announced today results ... investigational compound tiotropium delivered once-daily via the ... symptomatic, moderate persistent asthma. The data were ... the American Thoracic Society (ATS 2012). Boehringer ... III trial program named UniTinA-asthma™ is ongoing ...
(Date:5/22/2012)... 2012 Accuray Incorporated (Nasdaq: ... company, announced today the signing of a multi-year ... German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) ... Accuray and DKFZ will collaborate on cutting-edge research ... provide health care professionals with the most effective ...
Breaking Medicine Technology:MusclePharm Signs Pro Baseball Rookie Phenom Bryce Harper As Sponsored Athlete 2Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma 2Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma 3Boehringer Ingelheim Presents First Data for Tiotropium in Adolescents with Moderate Persistent Asthma 4Accuray and the German Cancer Research Center Sign Master Research and Collaboration Agreement 2Accuray and the German Cancer Research Center Sign Master Research and Collaboration Agreement 3Accuray and the German Cancer Research Center Sign Master Research and Collaboration Agreement 4International Health Leaders to Share Innovations in Patient Centered Care at 2009 Planetree Annual Conference 52555 1International Health Leaders to Share Innovations in Patient Centered Care at 2009 Planetree Annual Conference 52555 2International Health Leaders to Share Innovations in Patient Centered Care at 2009 Planetree Annual Conference 52555 3Moore Unique Skin Care Announces the Release of Eventone Glycolic Texturizer for Men and Women 52552 1Moore Unique Skin Care Announces the Release of Eventone Glycolic Texturizer for Men and Women 52552 2FDA Approves Expanded Use of Lillys FORTEO 28R 29 5Bteriparatide 28rDNA origin 29 injection 5D to Treat Glucocorticoid Induced Osteoporosis 52548 1FDA Approves Expanded Use of Lillys FORTEO 28R 29 5Bteriparatide 28rDNA origin 29 injection 5D to Treat Glucocorticoid Induced Osteoporosis 52548 2FDA Approves Expanded Use of Lillys FORTEO 28R 29 5Bteriparatide 28rDNA origin 29 injection 5D to Treat Glucocorticoid Induced Osteoporosis 52548 3FDA Approves Expanded Use of Lillys FORTEO 28R 29 5Bteriparatide 28rDNA origin 29 injection 5D to Treat Glucocorticoid Induced Osteoporosis 52548 4FDA Approves Expanded Use of Lillys FORTEO 28R 29 5Bteriparatide 28rDNA origin 29 injection 5D to Treat Glucocorticoid Induced Osteoporosis 52548 5FDA Approves Expanded Use of Lillys FORTEO 28R 29 5Bteriparatide 28rDNA origin 29 injection 5D to Treat Glucocorticoid Induced Osteoporosis 52548 6
... effective in a,mouse model of Chronic Lymphocytic ... Santaris Pharma, the Danish,biopharmaceutical company developing RNAi ... Association for Cancer,Research Annual Meeting in Los ... of Bcl-2, is therapeutically active in a,preclinical ...
... BOTHELL, Wash. & LOS ANGELES--(BUSINESS WIRE)--Apr 17, ... announced data from,fifteen presentations by the company ... of the American Association for Cancer Research,(AACR) ... (ADC) technology and cancer product,pipeline., ADCs are ...
Other Medicine Technology:Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 2Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 3Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 4Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 5Santaris Pharma presents positive preclinical data on SPC2996 at,the American Association for Cancer Research 6Seattle Genetics Highlights Data on its Proprietary Antibody-Drug,Conjugate Technology at AACR 2Seattle Genetics Highlights Data on its Proprietary Antibody-Drug,Conjugate Technology at AACR 3Seattle Genetics Highlights Data on its Proprietary Antibody-Drug,Conjugate Technology at AACR 4
3.0% Tryptone, 2.0% Yeast Extract, 1.0% MOPS free acid, 2.0% Glucose....
Listeria Enrichment Broth...
Tryptone is the pancreatic digest of casein used as a nitrogen source for bacteria. Ideal for general bacteriological use with a variety of microorganisms. Tryptone is guaranteed BSE-Free....
... compact model that combines simultaneous heating and ... Impressive features of the Thermomixer include the ... at maximum mixing frequency. Product features: adjustable ... including intermittent mixing; operates from 4C above ...
Medicine Products: